People
Herbert Torfs
Herbert Torfs is NBCL’s CEO and is also identified as Commercial Director in its December2025 investment announcement. He represents the company’s intraoperative diagnostics business at endocrine-surgery conferences and in its US market-development programme. The issuer’s2024 welcome describes experience in the diagnostics industry.
Roles
NBCL
CurrentCEO; Commercial Director (latter explicitly published December2025)